| Malinda K Johnson, MD | |
|
3960 Coon Rapids Blvd Nw, Suite 101, Coon Rapids, MN 55433-2569 | |
| (763) 236-9236 | |
| Not Available |
| Full Name | Malinda K Johnson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 3960 Coon Rapids Blvd Nw, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174585806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 45435 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Coon rapids, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
It seems everyone's talking about human growth hormone these days. CNN, Fox News, The Today Show, The Dr. Oz Show, Shape magazine… even Vanity Fair have all done features on hGH. Many of Hollywood's "elite" have been visiting some of the most expensive clinics in the world for controversial hGH therapy. Why? Because they believe human growth hormone can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Waiting times in hospital emergency departments could be cut with the introduction of Lean Management and Six Sigma techniques according to new research.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 4 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
It seems everyone's talking about human growth hormone these days. CNN, Fox News, The Today Show, The Dr. Oz Show, Shape magazine… even Vanity Fair have all done features on hGH. Many of Hollywood's "elite" have been visiting some of the most expensive clinics in the world for controversial hGH therapy. Why? Because they believe human growth hormone can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Waiting times in hospital emergency departments could be cut with the introduction of Lean Management and Six Sigma techniques according to new research.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 4 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
It seems everyone's talking about human growth hormone these days. CNN, Fox News, The Today Show, The Dr. Oz Show, Shape magazine… even Vanity Fair have all done features on hGH. Many of Hollywood's "elite" have been visiting some of the most expensive clinics in the world for controversial hGH therapy. Why? Because they believe human growth hormone can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Waiting times in hospital emergency departments could be cut with the introduction of Lean Management and Six Sigma techniques according to new research.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Malinda K Johnson, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Malinda K Johnson, MD 3960 Coon Rapids Blvd Nw, Suite 101, Coon Rapids, MN 55433-2569 Ph: (763) 236-9236 |
News Archive
It seems everyone's talking about human growth hormone these days. CNN, Fox News, The Today Show, The Dr. Oz Show, Shape magazine… even Vanity Fair have all done features on hGH. Many of Hollywood's "elite" have been visiting some of the most expensive clinics in the world for controversial hGH therapy. Why? Because they believe human growth hormone can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Waiting times in hospital emergency departments could be cut with the introduction of Lean Management and Six Sigma techniques according to new research.
Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 4 days ago
Nancy M Dickerson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3960 Coon Rapids Blvd Nw, Suite101, Coon Rapids, MN 55433 Phone: 763-236-9236 | |
Laura Mayer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11475 Robinson Dr Nw, Coon Rapids, MN 55433 Phone: 763-587-9000 Fax: 763-587-9130 | |
Dr. Seth A Myles, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11475 Robinson Drive Nw, Healthpartners Coon Rapids Clinic, Coon Rapids, MN 55433 Phone: 763-587-9000 Fax: 763-587-9130 | |
Bryan T Hotujec, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-9236 Fax: 763-684-6006 | |
Sarah Beth Schoel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, Suite 101, Coon Rapids, MN 55433 Phone: 763-236-9236 | |
Mark A Elias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, Suite101, Coon Rapids, MN 55433 Phone: 763-236-9236 |